Back Button
Download this free Back Button and use it right away. Optimized for A4 and Letter paper, all 100 designs are ready to print without editing software. No sign-up required.
How to Use This Back Button
- Browse the collectionScroll through the Back Button designs above and click any image to open it full size.
- Download the imageHit the Download button to save the full-resolution file to your device.
- Print on standard paperUse A4 or Letter paper. Select 'Fit to page' in your printer settings to ensure nothing is cut off.
- Use immediatelyNo editing, software, or account needed — it's ready the moment it comes out of the printer.
More Back Button Templates
Market design to accelerate COVID-19 vaccine supply | Science
Market design to accelerate COVID-19 vaccine supply | Science
Market design to accelerate COVID-19 vaccine supply | Science
Accelerating Vaccinations
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
SARS-CoV-2 vaccines in development | Nature
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine | npj Vaccines
Testing fractional doses of COVID-19 vaccines | PNAS
The Evolution of a Hospital-Based Covid-19 Vaccination Program for Inpatients | NEJM Catalyst
No one is safe until we are all safe | Science Translational Medicine
Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework | Humanities and Social Sciences Communications
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape | Nature Reviews Immunology
Implementation of an Inpatient Covid-19 Vaccination Program | NEJM Catalyst
Vaccines | Free Full-Text | The Safety of COVID-19 Vaccinations—We Should Rethink the Policy | HTML/cloudfront-us-east-2.images.arcpublishing.com/reuters/5HZTI54IU5KGHG64JTLKA7NS2I.jpg)
Australia looks to speed up COVID-19 vaccine rollout to over-50s | Reuters
Biomedical Research COVID-19 Impact Assessment: Lessons Learned and Compelling Needs - National Academy of Medicine
Vaccines | Free Full-Text | The Race for Global Equitable Access to COVID-19 Vaccines | HTML
Doing More with Less: Running a High-Volume Covid-19 Vaccination Site | Catalyst non-issue content
Vaccines | Free Full-Text | Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales | HTML
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact | Nature Reviews Immunology
Tracking COVID-19 vaccines and therapeutics | McKinsey
Best Practices for an Equitable Covid-19 Vaccination Program | NEJM Catalyst
Vaccines | Free Full-Text | Delivery Routes for COVID-19 Vaccines | HTML
COVID-19 vaccination mandates and vaccine uptake | Nature Human Behaviour
ABB robots help accelerate COVID-19 vaccine development in Thailand
Vaccine Finance and Epidemic Risk – IMF F&D
The 5 Stages of COVID-19 Vaccine Development: What You Need to Know About How a Clinical Trial Works | Johnson & Johnson
For Billion-Dollar COVID Vaccines, Basic Government-Funded Science Laid the Groundwork - Scientific American
Vaccines | Free Full-Text | A Global Study on the Correlates of Gross Domestic Product (GDP) and COVID-19 Vaccine Distribution | HTML
Global leaders rally to accelerate access to COVID-19 vaccines for lower-income countries | Gavi, the Vaccine Alliance
Covid-19 Vaccines for Homebound Patients and Their Caregivers | Catalyst non-issue content
A Guide to Global COVID-19 Vaccine Efforts | Council on Foreign Relations
Health Care Payers COVID-19 Impact Assessment: Lessons Learned and Compelling Needs - National Academy of Medicine
Gavi signs agreement with Clover Biopharmaceuticals for supply to COVAX | Gavi, the Vaccine Alliance
Vaccination Tracker for COVID-19 | UL Solutions
India Should Use the Market to Speed Up Covid-19 Vaccinations - Bloomberg
Designing Markets for Faster, Better Vaccines | Stanford Graduate School of Business
Amazon's COVID-19 blog
Here's how to get billions of COVID-19 vaccine doses to the world | PIIE
Shot of a Lifetime: How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time | Pfizer
Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report | Fierce Pharma
How to Vaccinate the World (Next Time) | Chicago Booth Review
No-fault compensation programme for COVID-19 vaccines is a world first | Gavi, the Vaccine Alliance
Covid-19 Vaccine Tracker: Latest Updates - The New York Times
Why the World Needs a Lot More Vaccine Capacity | Chicago Booth Review
17 pandemic innovations that are here to stay - POLITICO
COVID-19 Vaccine Equity | Pfizer
Japan Suspends 1.63 Million Doses Of Moderna COVID-19 Vaccine Over Contamination : NPR
COVID-19 and Superpower Competition: An Effective American Response > National Defense University Press > News Article View
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma
UL Launches Program to Support Safe and Effective COVID-19 Vaccine Manufacture, Distribution and Administration | UL Solutions
New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle-income countries | Gavi, the Vaccine Alliance
Cash incentives, ethics, and COVID-19 vaccination | Science
First COVID-19 COVAX vaccine doses administered in Africa
The Timelines and Implications for COVID-19 Vaccines | BCG
UNICEF to lead procurement and supply of COVID-19 vaccines in world's largest and fastest ever operation of its kind
Epidemiologia | Free Full-Text | Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies | HTML
COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show | Fierce Pharma
Opinion | How to Fix the Coronavirus Vaccine Rollout - The New York Times
POWERING VACCINE R&D: OPPORTUNITIES FOR TRANSFORMATION - The Sabin-Aspen Vaccine Science & Policy Group
The Case for a Coronavirus-Vaccine Bond | The New Yorker
World leaders unite to commit to global equitable access for COVID-19 vaccines | Gavi, the Vaccine Alliance
UNICEF To Stockpile Over Half A Billion Syringes For Future COVID-19 Vaccine : Coronavirus Updates : NPR
COVID-19 tracker: Japan cancels part of AZ vaccine order | Fierce Pharma
Inside the Quest for a COVID-19 Vaccine | The New York Academy of Sciences
Vaccines | Free Full-Text | Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach | HTML
Covid-19: efforts and initiatives to end global vaccine inequity
COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout
Covid-19: Studies Indicate Pfizer-BioNTech Vaccine Protects Against the Most Severe Outcomes of Some Virus Variants - The New York Times
Covid-19 outbreak: the key to quicker vaccine development - Pharmaceutical Technology
Accelerating the timeline for Covid-19 vaccine will take collaboration
Messages from the COVID-19 Response Task Force | AAAAI Education Center/cloudfront-us-east-1.images.arcpublishing.com/gray/XR6VPUTGWRC67BVGUVJ5W7CUSQ.png)
It's cheap, easy to make and in demand overseas. So why can't this Texas-born COVID-19 vaccine break into the U.S. market?
Covid-19: F.D.A. Panel Gives Green Light to Johnson & Johnson's Vaccine - The New York Times
Pfizer Boosts EU Covid Vaccine Supply as J&J Review Accelerates - Bloomberg
Chart: Is The EU's Vaccination Campaign Set For Liftoff? | Statista
Remdesivir: FDA will reportedly authorize use for Covid-19 after trial shows 'positive effect' on recovery time | CNN
DATA in the time of COVID-19 – Open Data Watch
COVID-19 Thought Leadership Digest | The University of Chicago Booth School of BusinessBack Button
Researchers getting closer to a “universal” flu vaccine | PNAS
Covid-19: The world has the tools to end the pandemic. They're not being used properly | CNN
How COVID‐19 vaccine supply chains emerged in the midst of a pandemic - Bown - 2022 - The World Economy - Wiley Online Library
Ways Health Departments Can Help Increase COVID-19 Vaccinations | CDC
How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight - The New York Times
The vaccine moonshot - Montana Free Press
How COVID‐19 vaccine supply chains emerged in the midst of a pandemic - Bown - 2022 - The World Economy - Wiley Online Library
Oxford's Plan to Better Prepare for the Next Pandemic - Bloomberg
Geographically targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone | Science Advances
UNSDG | Updates from the field #40: UN teams carry on the battle against COVID-19
The Case for U.S. Investment in Global COVID-19 Vaccinations - CARE
Covid-19 vaccine mixing: the good, the bad and the uncertain
Creating Advanced Market Commitments and Prizes for Pandemic Preparedness | Day One Project
Gavi signs agreement with Novavax to secure doses on behalf of COVAX Facility | Gavi, the Vaccine Alliance
Back Button
Regeneron targets September data drop from COVID-19 antibody trial
How to build more secure, resilient, next-gen U.S. supply chains
J&J signs Covid-19 vaccine purchase agreement with AVAT
Salesforce Announces Vaccine Cloud to Accelerate Global Vaccine Management - Salesforce NewsFrequently Asked Questions
Is this Back Button free to use?
Yes, 100% free. Download and print without creating an account or providing your email address.
What paper size does this template support?
Templates are designed for A4 and US Letter paper. Select 'Fit to page' in your printer dialog for the best fit.
Can I print multiple copies?
Yes. Once you download the image, you can print it as many times as you like for personal or educational use.